LifeVantage won’t issue FY27 outlook after CEO transition
LifeVantage said it is not issuing formal fiscal 2027 guidance at this time due to a recent transition in the Chief Executive Officer role.
LifeVantage Corporation (NASDAQ: LFVN ), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced due to the recent transition in the Chief Executive Officer role, the Company is not issuing formal guidance for fiscal 2027 at this time.